Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis

Completed · Phase 4 · Has a placebo group

Conditions studied: Hypotrichosis

In brief

This study will evaluate the safety and efficacy of bimatoprost solution 0.03% once daily to the upper eyelid margins (where the eyelashes meet the skin) compared with vehicle in increasing overall eyelash prominence in self-identified African American/ethnic black subjects exhibiting hypotrichosis of the eyelashes (inadequate or not enough eyelashes).

Key facts

Study ID

NCT00958035

Run by

Allergan

People needed

89

Starts

2009-11-01

Expected to finish

2010-08-01

Last updated by the study team

2012-01-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• African American/ethnic black
• Adults at least 18 years of age
• Eyelash prominence assessment of minimal or moderate

You may not qualify if…

• Subjects with uneven lashes or longer on one side than the other
• Any eye disease or abnormality
• Eye surgery
• Severe hyperpigmentation around the eye
• Eyelash implants
• Eyelash extension application
• Any use of eyelash growth products within 6 months
• Any use of prescription eyelash growth products
• Treatments that may affect hair growth
• Requiring eye drop medications for glaucoma

Where it is running

• Study site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.